Yes. Cytos Biotechnology AG was formerly owned by 1 private investor.
Cytos Biotechnology AG is headquartered in Schlieren, Switzerland.
Cytos Biotechnology AG is a healthcare services company.
Wagistrasse 25 Postfach,
Schlieren,
8952
Switzerland,
www.cytos.com
Cytos is a public biopharmaceutical company focused on the development of targeted immunotherapies. The Company’s lead product candidate CYT003 is a first-in-class biologic in Phase 2 clinical development as a potential new treatment for allergic asthma.
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
